MapLight Therapeutics Inc

Research MapLight Therapeutics Inc (MPLT) on Bullrun: market cap USD 1.56B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMPLT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.56B
• Financial periodFY2025
• Net income-USD 161.15M
• Free cash flow-USD 138.61M

Valuation Snapshot

latest market cap is USD 1.56B.

About MapLight Therapeutics Inc

MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer's disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson's disease;

Frequently asked questions

What is MapLight Therapeutics Inc's market cap?

MapLight Therapeutics Inc's market capitalization is USD 1.56B.

What does MapLight Therapeutics Inc do?

MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.